Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea

Clinical trial NCT01154244 · COMPLETED

Trial details

NCT number: NCT01154244
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2009-09-01
Primary completion: 2010-07-01
Enrollment: 1439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.